Patent details
EP4243825 Title: OMECAMTIV MECARBIL FOR THE TREATMENT OF HEART FAILURE IN SELECTED PATIENT GROUPS
Basic Information
- Publication number:
- EP4243825
- PCT Application Number:
- US2021058988
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP218204089
- PCT Publication Number:
- WO2022103966
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- OMECAMTIV MECARBIL FOR THE TREATMENT OF HEART FAILURE IN SELECTED PATIENT GROUPS
- French Title of Invention:
- OMECAMTIV MECARBIL POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE CHEZ DES GROUPES DE PATIENTS SÉLECTIONNÉS
- German Title of Invention:
- OMECAMTIV MECARBIL ZUR BEHANDLUNG VON HERZINSUFFIZIENZ BEI AUSGEWÄHLTEN PATIENTENGRUPPEN
- SPC Number:
Dates
- Filing date:
- 11/11/2021
- Grant date:
- 12/11/2025
- EP Publication Date:
- 20/09/2023
- PCT Publication Date:
- 19/05/2022
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/11/2025
- EP B1 Publication Date:
- 12/11/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 11/11/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/11/2025
- Name:
- Amgen Inc.
- Address:
- One Amgen Center Drive, Thousand Oaks, California 91320, United States (US)
- Name:
- Cytokinetics, Inc.
- Address:
- 350 Oyster Point Blvd, South San Francisco CA 94080, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 24/11/2025
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- MALIK, Fady
- Address:
- United States (US)
2
- Name:
- HONARPOUR, Narimon
- Address:
- United States (US)
Priority
1
- Priority Number:
- 202063112995 P
- Priority Date:
- 12/11/2020
- Priority Country:
- United States (US)
2
- Priority Number:
- 202163154077 P
- Priority Date:
- 26/02/2021
- Priority Country:
- United States (US)
3
- Priority Number:
- 202163187084 P
- Priority Date:
- 11/05/2021
- Priority Country:
- United States (US)
4
- Priority Number:
- 202163202873 P
- Priority Date:
- 28/06/2021
- Priority Country:
- United States (US)
5
- Priority Number:
- 202163203436 P
- Priority Date:
- 22/07/2021
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/496; A61K 45/06; A61K 9/00; A61P 9/04; A61P 7/04; A61P 9/10; A61K 9/20;
Publication
European Patent Bulletin
1
- Issue number:
- 202546
- Publication date:
- 12/11/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202551
- Publication date:
- 17/12/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 30/11/2026
- Annual Fee Number:
- 6
- Annual Fee Amount:
- 66 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 24/11/2025 | Power Of Attorney | 1 |
| 25/11/2025 | Outgoing Correspondence | 1 |